Emerging pharmaceutical innovations are poised to reshape the treatment landscape for binge eating disorder. Traditionally, cognitive-behavioral therapy (CBT) has been seen as the go-to treatment, but recent developments suggest a shift towards pharmacological options. Advances in neurobiology, for example, have opened up new possibilities for disorder-specific medications, targeting the underlying...
Discover more insights